MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Government: International
North America
United States of America
Government: U.S. States & Territories
Government: States (U.S.)
Pennsylvania
*Industry: Pennsylvania
ArriVent BioPharma, Inc. (NASDAQ:AVBP)
Organization & Developments: ArriVent Biopharma
Parents
ArriVent BioPharma, Inc. (NASDAQ:AVBP)
Children
*Founded to develop its Furmonertinib drug candidate for the treatment of non-small cell lung cancer, or NSCLC
*The firm is a clinical-stage biopharma developing treatments for lung cancer.
2024: ArriVent Biopharma Seeks $100 Million IPO For Lung Cancer Drug_seekingalpha.com
2024: ArriVent BioPharma: Bringing A Novel Cancer Drug From China
2024: ArriVent Wows Investors With Promising China-Developed Lung Cancer Treatment
Jumps
Finance & Acquisitions: ArriVent Biopharma
Key People: ArriVent Biopharma